Waters unveils UPLC solution
Waters has launched the first Ultra Performance LC (UPLC) analytical
size-exclusion chromatography (SEC) solution for the characterization
of proteins and their aggregates.
The UPLC solution combines the first commercial sub two-micron particle
for SEC applications- the new patent pending Acquity UPLC BEH200, 1.7
SEC Columns- with Waters' Acquity UPLC System to give manufacturers the
ability to separate and quantify monoclonal antibodies (mAb) and their
aggregates in less than four minutes, faster than conventional liquid
chromatography. The UPLC solution allows customers to monitor
monoclonal antibody aggregation at speeds up to 10 times faster than
other similar solutions, in order to overcome the challenges in
developing novel biotherapeutics in less time and at lower costs.
Millipore launches ICW-3000 system
Millipore has introduced ICW-3000 water purification system. The new
system produces a constant and reliable source of ultrapure water for
Dionex IC (ion chromatography) systems.
Ultrapure water from the ICW-3000 system can increase the precision of
IC analyses. The ICW-3000 system provides a continual flow of ultrapure
water to the eluent generator and regenerant lines of the suppressor.
This reduces the carbonate content in the water-sharply decreasing
contamination risks and improving experiment reproducibility, while
also eliminating the need for helium. The water system also eliminates
the need for eluent preparation and the instrument downtime that occurs
when filling eluent bottles.
Biotage introduces new peptide
Biotage has introduced Syro Wave-microwave and parallel peptide
synthesizer. The Syro Wave is a result of the joint development project
of Biotage and MultiSynTech. It combines the proven performance of the
established MultiSynTech robotic synthesizer with Biotage microwave
technology. The Syro Wave peptide synthesis system offers both
microwave and parallel peptide synthesis capabilities. Syro Wave
increases productivity, yield and purity while cutting costs and saving
MathWorks' new version of
MathWorks has introduced the latest version of SimBiology that provides
new features and enhanced performance capabilities, including multiple
dosing schemes, for pharmacokinetic/pharmacodynamic (PK/PD) modeling
and simulation of biological systems. Pharmacokineticists and
computational biologists use SimBiology to create, simulate, and
analyze both mechanistic and PK/PD models in one software environment.
SimBiology simplifies the modeling workflow and reduces simulation and
fitting times by providing a graphical interface for constructing
mechanistic models.Users can select from multiple fitting algorithms,
including stochastic approximation expectation-maximization (SAEM), and
compare results with other fitting algorithms. The tool's graphical
interface also enables users to apply multiple dosing schemes to their
models, eliminating the need to manually schedule dosing.